Company: UPC
Filing Date: 2025-02-11
Form Type: 6-K
Source: 0001213900-25-012207
Chunk: 1

Company: Universe Pharmaceuticals INC
Filing Date: 2025-02-11
Form: 6-K
Chunk 1
---
 as the Board may determine. The Company is holding an extraordinary meeting of shareholders on March 1, 2025 to give shareholder the opportunity to consider, and if thought fit, pass resolutions approving the Revised Share Consolidation and related matters, and hereby furnishes the documents set forth under the Exhibit Index below (the “Revised Meeting”). Given the Company intends to hold the Revised Meeting, the Board no longer considers it necessary for shareholders to consider the proposals that were intended to be presented to shareholders at the Original Meeting. Accordingly, upon the immediate commencement of the Original Meeting on February 17, 2025, the Chairman of the Original Meeting will ask shareholders to pass an ordinary resolution approving the indefinite adjournment of the Original Meeting. Exhibits

1

SIGNATURES Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

| Date: February 11, 2025 |     | Universe Pharmaceuticals INC 
 By:                          |     | /s/ Gang Lai            |
|:------------------------|:----|:-----------------------------|:----|:------------------------|
|                         |     |                              |     | Gang Lai                |
|                         |     |                              |     | Chief Executive Officer |

2